gsk development solutions ltd
gsk development solutions ltd Company Information
Company Number
09853556
Website
-Registered Address
31a kenilworth road, leamington spa, CV32 6JG
Industry
Development of building projects
Telephone
01926935001
Next Accounts Due
August 2025
Group Structure
View All
Shareholders
gary stephen kedgley 100%
gsk development solutions ltd Estimated Valuation
Pomanda estimates the enterprise value of GSK DEVELOPMENT SOLUTIONS LTD at £390.5k based on a Turnover of £846k and 0.46x industry multiple (adjusted for size and gross margin).
gsk development solutions ltd Estimated Valuation
Pomanda estimates the enterprise value of GSK DEVELOPMENT SOLUTIONS LTD at £1.2m based on an EBITDA of £332.7k and a 3.46x industry multiple (adjusted for size and gross margin).
gsk development solutions ltd Estimated Valuation
Pomanda estimates the enterprise value of GSK DEVELOPMENT SOLUTIONS LTD at £514.3k based on Net Assets of £394.1k and 1.31x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Gsk Development Solutions Ltd Overview
Gsk Development Solutions Ltd is a live company located in leamington spa, CV32 6JG with a Companies House number of 09853556. It operates in the development of building projects sector, SIC Code 41100. Founded in November 2015, it's largest shareholder is gary stephen kedgley with a 100% stake. Gsk Development Solutions Ltd is a young, small sized company, Pomanda has estimated its turnover at £846k with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Gsk Development Solutions Ltd Health Check
Pomanda's financial health check has awarded Gsk Development Solutions Ltd a 2 rating. We use a traffic light system to show it exceeds the industry average on 1 measures and has 7 areas for improvement. Company Health Check FAQs
1 Strong
3 Regular
7 Weak
Size
annual sales of £846k, make it smaller than the average company (£2.5m)
- Gsk Development Solutions Ltd
£2.5m - Industry AVG
Growth
3 year (CAGR) sales growth of -20%, show it is growing at a slower rate (3.3%)
- Gsk Development Solutions Ltd
3.3% - Industry AVG
Production
with a gross margin of 26.4%, this company has a comparable cost of product (26.4%)
- Gsk Development Solutions Ltd
26.4% - Industry AVG
Profitability
an operating margin of 38.1% make it more profitable than the average company (6.7%)
- Gsk Development Solutions Ltd
6.7% - Industry AVG
Employees
with 3 employees, this is below the industry average (6)
- Gsk Development Solutions Ltd
6 - Industry AVG
Pay Structure
on an average salary of £49.7k, the company has an equivalent pay structure (£49.7k)
- Gsk Development Solutions Ltd
£49.7k - Industry AVG
Efficiency
resulting in sales per employee of £282k, this is equally as efficient (£301.3k)
- Gsk Development Solutions Ltd
£301.3k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- Gsk Development Solutions Ltd
- - Industry AVG
Creditor Days
its suppliers are paid after 26 days, this is quicker than average (30 days)
- Gsk Development Solutions Ltd
30 days - Industry AVG
Stock Days
it holds stock equivalent to 820 days, this is more than average (179 days)
- Gsk Development Solutions Ltd
179 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 1 weeks, this is less cash available to meet short term requirements (12 weeks)
1 weeks - Gsk Development Solutions Ltd
12 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 82.3%, this is a higher level of debt than the average (74.2%)
82.3% - Gsk Development Solutions Ltd
74.2% - Industry AVG
GSK DEVELOPMENT SOLUTIONS LTD financials
Gsk Development Solutions Ltd's latest turnover from November 2023 is estimated at £846 thousand and the company has net assets of £394.1 thousand. According to their latest financial statements, we estimate that Gsk Development Solutions Ltd has 3 employees and maintains cash reserves of £34.4 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Nov 2023 | Nov 2022 | Nov 2021 | Nov 2020 | Nov 2019 | Nov 2018 | Nov 2017 | Nov 2016 | |
|---|---|---|---|---|---|---|---|---|
| Turnover | ||||||||
| Other Income Or Grants | ||||||||
| Cost Of Sales | ||||||||
| Gross Profit | ||||||||
| Admin Expenses | ||||||||
| Operating Profit | ||||||||
| Interest Payable | ||||||||
| Interest Receivable | ||||||||
| Pre-Tax Profit | ||||||||
| Tax | ||||||||
| Profit After Tax | ||||||||
| Dividends Paid | ||||||||
| Retained Profit | ||||||||
| Employee Costs | ||||||||
| Number Of Employees | ||||||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Nov 2023 | Nov 2022 | Nov 2021 | Nov 2020 | Nov 2019 | Nov 2018 | Nov 2017 | Nov 2016 | |
|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 364,667 | 33,263 | 40,696 | 51,802 | 17,359 | 46,126 | 34,656 | 3,855 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 364,667 | 33,263 | 40,696 | 51,802 | 17,359 | 46,126 | 34,656 | 3,855 |
| Stock & work in progress | 1,400,000 | 2,786,500 | 2,321,100 | 2,650,000 | 2,566,000 | 2,895,540 | 1,153,000 | 1,100,000 |
| Trade Debtors | 0 | 0 | 0 | 0 | 386,113 | 0 | 0 | 0 |
| Group Debtors | 350,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 78,284 | 8,932 | 23,846 | 12,822 | 3,932 | 5,017 | 16,629 | 27,522 |
| Cash | 34,397 | 18,311 | 140,847 | 56,454 | 433 | 223,098 | 14,604 | 70,075 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 1,862,681 | 2,813,743 | 2,485,793 | 2,719,276 | 2,956,478 | 3,123,655 | 1,184,233 | 1,197,597 |
| total assets | 2,227,348 | 2,847,006 | 2,526,489 | 2,771,078 | 2,973,837 | 3,169,781 | 1,218,889 | 1,201,452 |
| Bank overdraft | 10,341 | 35,365 | 16,565 | 11,929 | 139,228 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 44,623 | 71,136 | 90,000 | 114,844 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 631,788 | 1,503,693 | 878,559 | 1,831,847 | 2,254,587 | 1,493,423 | 994,018 | 847,118 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 522,529 | 491,441 | 428,492 | 313,458 | 251,540 | 98,097 | 50,827 | 3,300 |
| total current liabilities | 1,209,281 | 2,101,635 | 1,413,616 | 2,272,078 | 2,645,355 | 1,591,520 | 1,044,845 | 850,418 |
| loans | 591,012 | 538,089 | 797,829 | 0 | 0 | 1,453,463 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 105,626 | 0 | 0 | 0 | 381,136 |
| provisions | 32,981 | 7,732 | 7,732 | 9,842 | 3,298 | 6,730 | 6,585 | 0 |
| total long term liabilities | 623,993 | 545,821 | 805,561 | 115,468 | 3,298 | 1,460,193 | 6,585 | 381,136 |
| total liabilities | 1,833,274 | 2,647,456 | 2,219,177 | 2,387,546 | 2,648,653 | 3,051,713 | 1,051,430 | 1,231,554 |
| net assets | 394,074 | 199,550 | 307,312 | 383,532 | 325,184 | 118,068 | 167,459 | -30,102 |
| total shareholders funds | 394,074 | 199,550 | 307,312 | 383,532 | 325,184 | 118,068 | 167,459 | -30,102 |
| Nov 2023 | Nov 2022 | Nov 2021 | Nov 2020 | Nov 2019 | Nov 2018 | Nov 2017 | Nov 2016 | |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Operating Profit | ||||||||
| Depreciation | 10,086 | 10,569 | 13,369 | 7,386 | 5,788 | 9,660 | 1,640 | 457 |
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | ||||||||
| Stock | -1,386,500 | 465,400 | -328,900 | 84,000 | -329,540 | 1,742,540 | 53,000 | 1,100,000 |
| Debtors | 419,352 | -14,914 | 11,024 | -377,223 | 385,028 | -11,612 | -10,893 | 27,522 |
| Creditors | -26,513 | -18,864 | -24,844 | 114,844 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 31,088 | 62,949 | 115,034 | 61,918 | 153,443 | 47,270 | 47,527 | 3,300 |
| Deferred Taxes & Provisions | 25,249 | 0 | -2,110 | 6,544 | -3,432 | 145 | 6,585 | 0 |
| Cash flow from operations | ||||||||
| Investing Activities | ||||||||
| capital expenditure | ||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | ||||||||
| Financing Activities | ||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | -871,905 | 625,134 | -953,288 | -422,740 | 761,164 | 499,405 | 146,900 | 847,118 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 52,923 | -259,740 | 797,829 | 0 | -1,453,463 | 1,453,463 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | -105,626 | 105,626 | 0 | 0 | -381,136 | 381,136 |
| share issue | ||||||||
| interest | ||||||||
| cash flow from financing | ||||||||
| cash and cash equivalents | ||||||||
| cash | 16,086 | -122,536 | 84,393 | 56,021 | -222,665 | 208,494 | -55,471 | 70,075 |
| overdraft | -25,024 | 18,800 | 4,636 | -127,299 | 139,228 | 0 | 0 | 0 |
| change in cash | 41,110 | -141,336 | 79,757 | 183,320 | -361,893 | 208,494 | -55,471 | 70,075 |
gsk development solutions ltd Credit Report and Business Information
Gsk Development Solutions Ltd Competitor Analysis
Perform a competitor analysis for gsk development solutions ltd by selecting its closest rivals and benchmarking them against 12 key performance metrics.
gsk development solutions ltd Ownership
GSK DEVELOPMENT SOLUTIONS LTD group structure
Gsk Development Solutions Ltd has 4 subsidiary companies.
Ultimate parent company
GSK DEVELOPMENT SOLUTIONS LTD
09853556
4 subsidiaries
gsk development solutions ltd directors
Gsk Development Solutions Ltd currently has 2 directors. The longest serving directors include Mr Gary Kedgley (Nov 2015) and Dr Helen Coleman (Dec 2017).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Gary Kedgley | England | 65 years | Nov 2015 | - | Director |
| Dr Helen Coleman | England | 57 years | Dec 2017 | - | Director |
P&L
November 2023turnover
846k
-48%
operating profit
322.7k
0%
gross margin
26.5%
+6.5%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
November 2023net assets
394.1k
+0.97%
total assets
2.2m
-0.22%
cash
34.4k
+0.88%
net assets
Total assets minus all liabilities
Similar Companies
gsk development solutions ltd company details
company number
09853556
Type
Private limited with Share Capital
industry
41100 - Development of building projects
incorporation date
November 2015
age
9
accounts
Total Exemption Full
ultimate parent company
previous names
N/A
incorporated
UK
address
31a kenilworth road, leamington spa, CV32 6JG
last accounts submitted
November 2023
gsk development solutions ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 8 charges/mortgages relating to gsk development solutions ltd. Currently there are 2 open charges and 6 have been satisfied in the past.
gsk development solutions ltd Companies House Filings - See Documents
| date | description | view/download |
|---|
